AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the findings and implications of a recent randomized controlled trial of AR19 in adult ADHD.
Insights August 24, 2021
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
Vol 86 • 2025 • Number 4
Read the Current Issue
Original Research
Effects of Interpersonal and Social Rhythm Therapy on Suicidal Ideation in Adults with Bipolar II Depression
Academic Highlights
Real-World Implementation of Xanomeline-Trospium in Schizophrenia: A Consensus Panel Report
Academic Highlights
Psychosocial Interventions and Functional Recovery in Schizophrenia
Original Research
Symptom Network Analysis of ADHD and Emotional Symptoms in Adults
Original Research
Emory Treatment Resistance Interview for PTSD—Short Version
Original Research